Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Human cancer cell lines are immortalized cell populations derived from human tumors that are capable of indefinite proliferation in laboratory cultures (Masters, 2000, Nature Reviews Cancer). They serve as the workhorse of oncology research, providing a scalable and reproducible platform for studying cancer biology and evaluating the efficacy of potential therapeutic agents (Gillet et al., 2013, Journal of the National Cancer Institute). These cell lines are used in high-throughput screening to identify compounds that inhibit cell growth or induce cell death, often through specific molecular targets like kinases or receptors (NCI-60 Human Tumor Cell Line Screen, NIH). While they are essential for early-stage drug discovery, they are considered experimental models rather than therapeutic targets themselves. A significant challenge in using these lines is that they often fail to capture the complexity of the tumor microenvironment and can undergo genetic drift, leading to results that may not translate to clinical settings (Ben-David et al., 2018, Nature). Furthermore, cross-contamination and misidentification remain persistent issues in the field, necessitating rigorous authentication (Capes-Davis et al., 2010, International Journal of Cancer).
Not applicable; human cancer cell lines are experimental model systems used to evaluate drug effects rather than being molecular targets themselves.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human cancer cell lines.